Takeda Pharmaceutical: Overall, Adverse Events Were Reported in 89.4% of Patients. AES Related to Hyqvia Were Reported in 60% of Patients
武田製藥:總體而言,89.4%的患者報告了不良事件。與Hyqvia有關的AES在60%的患者中報告。
Takeda Pharmaceutical: Overall, Adverse Events Were Reported in 89.4% of Patients. AES Related to Hyqvia Were Reported in 60% of Patients
武田製藥:總體而言,89.4%的患者報告了不良事件。與Hyqvia有關的AES在60%的患者中報告。
譯文內容由第三人軟體翻譯。